Rivastigmine as a Treatment for Methamphetamine Dependence

Clinical trial NCT01073319 · COMPLETED

Trial details

NCT number: NCT01073319
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Methamphetamine Dependence Substance Abuse Methamphetamine Abuse

Start date: 2009-07-01
Primary completion: 2010-07-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.